BENZENO SHARON bought ADPT
November 20, 2025 · Form 4 insider transaction
BENZENO SHARON bought 133,032 shares of Adaptive Biotechnologies Corporation at $8.46 per share, a transaction worth $1.13M. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
133,032
Price
$8.46
Total value
$1.13M
InsiderBENZENO SHARON
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 20, 2025
Filing dateNovember 24, 2025
Shares owned after525,755
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025.